APGE Financials
Apogee Therapeutics Inc - Financial statements & key metrics
Stock Price
$74.68
Market Cap
$5.19B
EPS
$-4.22
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-182.15M
EPS (Diluted)
$-3.30
Balance Sheet Highlights
Total Assets
$753.95M
Total Liabilities
$37.16M
Shareholders Equity
-
Cash & Equivalents
$141.79M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-171.17M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is APGE revenue?
View APGE's income statement for detailed revenue data.
Is APGE profitable?
APGE reported a loss of $182.15M in the most recent quarter.
What is APGE market cap?
APGE has a market capitalization of $5.19B, making it a mid-cap stock.
Does APGE have debt?
View APGE's balance sheet for debt information.
What is APGE cash flow?
Cash flow data is available in the full financial statements.